Simplifying Process Intensification
New, Scalable Platform Tools for Simplifying Process Intensification in Commercial Scale Single-Use Facilities
Watch this on-demand webinar showcasing how Sartorius is investing and developing in upstream and downstream intensified technologies and services that cater to the needs of the industry for tomorrow's biopharmaceutical manufacturing. In this session you will find out how process intensification tools will address the industry's challenges.
Discover how Process Intensification Tools will address the industry’s challenges
- Perfusion based PI approaches in upstream leads to higher productivity and flexibility and lower COGs
- Generation of high cell density cell banks resulting in intensified seed train and also inoculation of the main bioreactors at high cell density to achieve higher titers
- Future Intensified downstream processes using BioSMB MCC Chromatography and Modular Chromatography systems enabling a continuous and connected approach to achieve maximum efficiency
- Technologies resulting in upstream titers of 10 g/L and beyond are leading to an annual output of >1500 kg/year from a Single-Use or Hybrid facility making modular Single-Use facilities a reality
- Efficient downstream solutions to handle higher mass by applying process intensification technologies for both existing and new facilities at different scales
Meet Our Experts
Gerben Zijlstra
Process Technology Manager, Sartorius
Gerben Zijlstra has been working for Sartorius since 2016, where he is currently Process Technology Manager for Cell Culture Technologies. He has driven process intensification (PI) projects and has been involved in several in-house PI technology developments and improvements, as well as external collaborations and acquisitions. He earned his PhD from the University of Wageningen, The Netherlands, in the field of process integration in animal cell culture.
Tom Erdenberger
Senior Platform Technology Consultant, Segment Marketing Proteins
Tom has worked in the biotechnology industry for more than 30 years both as an end-user as well as on the supplier side and has an extensive background in industrial microbiology, bioprocess development, cGMP manufacturing, tech transfer, facility start-up, cross-functional project management, and bioprocess/bioproduct engineering. Tom holds a position as Senior Platform Technology Consultant in the Protein Market Segment.